







As the first terminally ill cancer patient in Canada to legally use so-called magic mushrooms to treat anxiety, Thomas Hartle is hopeful that more temporary approvals from the federal government signal a permanent regulatory regime may be in the works.
Toronto's CAMH gets 1st federal grant to study magic mushrooms as treatment for depression | CBC News
Toronto's Centre for Addiction and Mental Health (CAMH) says it has received the first-ever federal grant to study whether the active component in 'magic' mushrooms can be used to treat depression without the psychedelic effects.

The Push to Legalize Magic Mushrooms for Depression and PTSD
Activists, entrepreneurs, and doctors in the US and Canada are working to decriminalize psilocybin psychotherapy and calling for a psychedelic revolution.

We May Finally Know How Magic Mushrooms Work to Relieve Depression
Mind-blowing stuff!

From treating PTSD to quitting tobacco: researchers say public investment into psychedelic drugs essential | CBC News
Magic mushrooms to treat depression, ecstasy to cure PTSD and LSD to combat alcoholism; just some of the drug-affliction pairings that have been tested in recent years.

A Dose of a Hallucinogen From a ‘Magic Mushroom,’ and Then Lasting Peace (Published 2016)
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.

Magic Mushroom Drug Lifts Depression in Human Trial
Psilocybin shows higher remission rate than SSRI drugs in a U.K. study

Canadian patients fighting for psilocybin access sue federal government
‘This is the landmark case that is going to legalize psychedelics in Canada’

How Magic Mushrooms Can Help Smokers Kick The Habit : Short Wave
Magic mushrooms — they're not just for getting weird with your friends. Researchers are increasingly looking at psychedelics to treat conditions such as depression and addiction.

A single high dose of psilocybin alters brain function up to one month later
New research provides evidence that the active ingredient in so-called magic mushrooms can affect brain processes related to emotional functioning long

Researchers are giving religious leaders psychedelic drugs in the interest of science
Despite the fact that psychedelic drugs have been used for millennia as medicine in ritualistic ceremonies, there remain many questions in the scientific community about the relationship between their spiritual qualities and healing potential. Researchers at Johns Hopkins and New York Universities are giving psilocybin, the active ingredient in magic mushrooms, to ordained ministers in the hopes that they can help provide some answers.

Why more B.C. health-care workers are training to provide MDMA-assisted psychotherapy | CBC News
As more promising research emerges about MDMA — a recreational drug also known as ecstasy or molly — so too has interest grown in how health-care practitioners can be equipped to treat their patients using MDMA, says a B.C. non-profit.

I have ADHD and was scared of psychedelics. Then I found myself eating magic truffles ... | Deborah Frances-White
The safe, repetitive domesticity of lockdown made me face my demons and seek therapy, while also making me hungry for sensation and risk. So I set off for a retreat in Amsterdam

New psychedelic research sheds light on why psilocybin-containing mushrooms have been consumed for centuries
A new study from the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine provides insight into the

Scientists studying psychoactive drugs accidentally proved the self is an illusion
Philosophers and mystics have long contemplated the disconcerting notion that the fixed self is an illusion. Neuroscientists now think they can prove it or, at least, help us glimpse this truth with some help from psilocybin, the psychoactive property in magic mushrooms.

Reefer Madness or Pot Paradise? The Surprising Legacy of the Place Where Legal Weed Began (Published 2019)
Colorado’s first-in-the-nation experiment with legalized marijuana has infused the drug into almost every corner of life.

Psilocybin for major depression granted Breakthrough Therapy by FDA
The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).
